Bausch Health (Germany) Today
| BVF Stock | EUR 7.51 0.09 1.18% |
Performance16 of 100
| Odds Of DistressOver 52
|
Bausch Health is trading at 7.51 as of the 26th of November 2024. This is a 1.18 percent decrease since the beginning of the trading day. The stock's lowest day price was 7.51. Bausch Health has 52 percent odds of going through some form of financial distress in the next two years but had a very solid returns during the last 90 days. Equity ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. The company has 361.87 M outstanding shares. More on Bausch Health Companies
Moving against Bausch Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bausch Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bausch Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bausch Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Thomas Appio |
| Thematic Idea | Health Management (View all Themes) |
| Business Concentration | Health Management, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Bausch Health Companies (BVF) is traded on Frankfurt Exchange in Germany and employs 19,900 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bausch Health's market, we take the total number of its shares issued and multiply it by Bausch Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bausch Health Companies classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 361.87 M outstanding shares.
Bausch Health Companies has accumulated about 782 M in cash with 1.43 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22.
Check Bausch Health Probability Of Bankruptcy
Ownership AllocationBausch Health holds a total of 361.87 Million outstanding shares. The majority of Bausch Health Companies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bausch Health Companies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bausch Health. Please pay attention to any change in the institutional holdings of Bausch Health Companies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bausch Ownership Details
Bausch Health Companies Risk Profiles
Although Bausch Health's alpha and beta are two of the key measurements used to evaluate Bausch Health's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.01 | |||
| Semi Deviation | 1.34 | |||
| Standard Deviation | 2.93 | |||
| Variance | 8.59 |
Bausch Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bausch Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Bausch Health Corporate Management
Elected by the shareholders, the Bausch Health's board of directors comprises two types of representatives: Bausch Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bausch. The board's role is to monitor Bausch Health's management team and ensure that shareholders' interests are well served. Bausch Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bausch Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeff Hartness | Commercial Access | Profile | |
| Kathleen Fitzpatrick | VP Officer | Profile | |
| John Barresi | Controller VP | Profile | |
| Arthur Shannon | IR Contact Officer | Profile | |
| Seana Carson | Exec Counsel | Profile | |
| Tage MD | Chief RD | Profile | |
| Robert Butz | VP Affairs | Profile |
Additional Information and Resources on Investing in Bausch Stock
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.